Sunshine Biopharma Inc. (SBFM) stock
SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/30
$2.41−0.13 (-5.12%)
Close on Nov 18, 2026Market cap $9.34MP/E –Yield –
Sunshine Biopharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Sunshine Biopharma's price to sales ratio was 0.2× on Nov 11, 2026, against 35.4× a year earlier. Over the last 5 years it ranged from 0.0× to 101.7×, with a median of 21.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.2× | −29.8 |
| 2025 | Dec 31, 2025 | 30.0× | −6.4 |
| 2024 | Dec 31, 2024 | 36.4× | +35.7 |
| 2023 | Dec 29, 2023 | 0.7× | −48.6 |
| 2022 | Dec 30, 2022 | 49.2× | +47.5 |
| 2021 | Dec 31, 2021 | 1.8× | +0.7 |
| 2020 | Dec 31, 2020 | 1.1× | +1.1 |
| 2019 | Aug 27, 2019 | 0.0× | −0.0 |
| 2018 | Jul 10, 2018 | 0.0× | −0.0 |
| 2016 | Jul 29, 2016 | 0.0× | +0.0 |
| 2015 | Dec 31, 2015 | 0.0× | – |
See a number that looks wrong?